Sunday Afternoon: Arrival and Registration

• C.C. Liew, Brigham and Women's Hospital
  "Overview - From EST to Quantitative Genomics: Current Perspectives in Cardiovascular Medicine"
• Richard Lawn, CV Therapeutics, Palo Alto, CA USA
  "Discovery of cardiovascular targets using microarray technology: Macrophoge & HDL pathways"
• Bruce Conklin, Gladstone Institute, San Francisco, CA USA
  "Genomic responses to signaling of engineered receptors and G protein in vivo"
• Richard Pratt, Brigham and Women's Hospital, Boston, MA
  "Signaling and physiological effect of AT2 receptor"
• Panel discussion on Techniques and Bioinformatics

• Jojo Haendeler, Germany
  "Git-1: A molecular switch that control angiotensin II signal transduction"
• Peter Sayeski, University of Florida, Gainesville, FL
  "JAK STAT in AngII Signaling"
• Tadeshi Inagami, University of Vanderbilt, Nashville, TN
  "SHP-2 in AngII signaling"
• Pam Lucchesi, University of Alabama at Birmingham, Birmingham, AL
  "PYKing your way from the AT1 receptor to vascular smooth muscle cell growth"

• Darren Richard, Centre de Recherche, CHUQA, Quebec, Canada,
  "Vasoactive hormones and hypoxia in the control of vascular endothelial growth factor"
• Masuko Ushio-Fukai, Emory University, Atlanta, GA
  "Mechanisms of angiotensin II-induced angiogenesis: role of oxidant stress"
• Christopher Wilcox, Georgetown University Medical Center, Washington, DC
  "Angiotensin II-induced oxidative stress and nephron hypoxia in hypertensive kidney"
• Ernesto Schiffrin, Institut de recherches cliniques de Montreal, Quebec CANADA
  "Superoxide generation in resistance vessels from normotensive and hypertensive patients"

• Volkhard Lindner, Maine Medical Center Research Institute, South Portland, ME
  "Genetic aspects of vascular remodeling in mice"
• Andrew Greene, Medical College of Wisconsin, Milwaukee, WI
  "Microvascular angiogenesis - an essential role for the renin-angiotensin system"
• Joseph deMey, Maastricht, Holland
  "Interactions of angiotensin and cytoskeleton in vascular remodeling"
• W. Robert Taylor, Emory University, Atlanta, GA
  "Angiotensin II and atherosclerosis, mechanistic insights"

• Colin Sumners, University of Florida, Gainesville, FL
  "AT2-AS Gene transfer"
• Robert Carey, University of Virginia Health Sciences Center, Charlottesville, VA
  "Expression and functional significance of AT2 receptor in the periphery"
• Helmy Siragy, University of Virginia Health Sciences Center, Charlottesville, VA
  "AT2 receptor and renal function"
• Sadashiva Karnik, The Cleveland Clinic Foundation, Cleveland, OH
  "Ligand independent signaling from AT2 receptor"

• Kirk Thomas, Howard Hughes Medical Institute, Salt Lake City, Utah
  "New strategies in genetic targeting: designing knockout mice in the 21st century"
• Curt Sigmund, University of Iowa, Iowa City, IA
  "Organ specific knockout of the renin-angiotensin system"
• Tom Coffmann, Duke University Medical Center, Durham, NC
  "The biology of the AT1 receptor explored using knockout mice"
• Justin Cole, Emory University, Atlanta GA
  "Selective knockout of angiotensin converting enzyme"

• Mona Nemer, University of Montreal, IRCM
  "Targeted overexpression of AT1 in mouse heart"
• Walter Thomas, Baker Medical Research Institute, Melbourne, Australia
  "Adenoviral mediated overexpression of AT1 in rat cardiac myocytes and fibroblasts"
• Keichi Fukada, Keio University School of Medicine, Tokyo, Japan
  "Role of AT1 JAK/STAT interactions in stretch mediated cardiomyocyte growth"
• Hiroaki Matsubara, Kansai Medical University, Osaka, Japan
  "Cardiac AT2 function unmasked by cardiomyocyte or SMC targeted overexpression in mice"

• Alan Daugherty, University of Kentucky, Lexington, KY
  "Angiotensin and Atherosclerosis"
• Nancy J. Brown, Vanderbilt University School of Medicine, Nashville, TN
  "Bradykinin metabolism and mechanisms of t-PA release"
• J.L. Mehta, University of Arkansas for Medical Sciences, Little Rock, AR
  "Angiotensin and the LOX receptor"

• Wayne Border, University of Utah, Salt Lake City, UT
  "TGF-beta: a critical factor in tissue fibrosis"
• Susanne Nicholas, University of California, LA
  "Angiotensin II, PPAR-gamma and PAI-1 the mesangium in diabetes"
• Agnes Fogo, Vanderbilt University, Nashville, TN
  "Angiotensin and PAI-1 potential targets for regression of sclerosis"
• Christine Maric, University of Melbourne, Australia
  "Osmotic regulation of angiotensin receptors in the renal medulla"

• Claude DelCayre, INSERM, Hopital Lariboisiere, Paris France
  "Interactions of cardiac tissular aldosterone and angiotensin II and their role in cardiac remodeling"
• Kathleen Kayes-Wandover, University of Texas Southwestern Medical Center, Dallas, TX
  "Aldosterone and the human heart"
• Annette Fiebeler, Franz Volhard Clinic, Berlin, Germany
  "Role of the mineralocorticoid receptor in the mediation of Ang II-induced vascular injury"

• Darren Roesch, Georgetown University, Washington, DC
  "Could an ovarian influence rejuvenate a troubled kidney? New thoughts on estrogens and adrenal and renal responsiveness to angiotensin"
• Steven Fluharty, University of Pennsylvania, Philadelphia, PA
  "Estrogen regulation of the central actions of Ang II"
• Bridget Brosnihan, Wake Forest
  "Bidirectional actions of estrogen on the renin angiotensin system"

• Suzanne Oparil, University of Alabama, Birmingham, AL
  "Human RAS"
• Bertram Pitt, University of Michigan Health Sytem, Ann Arbor, MI
  "ELITE I & II"
• Bjorn Dahlof, Ostra Hospital, University of Goteborg, Goteborg, Sweden
  "LIFE"
• Peter Sleight, Cardiovascular Medicine Department, John Radcliffe Hospital, Oxford, UK
  "HOPE"

• Pierre Corvol, College de France, Paris, France
  "Vasoactive peptides and angiogenesis"